Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: “Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period”.
Wolfgang Högler, Francis H. Glorieux, Anthony A. Portale, Michael P. Whyte, Craig F. Munns +16 more